SOURCE: Wolf Greenfield

January 09, 2007 16:22 ET

Supreme Court Rules in MedImmune Biotech Patent Case; Expert Lawyer Can Comment

BOSTON, MA -- (MARKET WIRE) -- January 9, 2007 -- The US Supreme Court today ruled for MedImmune in its case against Genentech, in a key biotech patent case.

The Supreme Court reversed the US Court of Appeals for the Federal Circuit and sent the case back to the lower courts. The decision affects broad issues in patent licensing and allows MedImmune to challenge the validity and scope of the specific biotech patent at hand.

Michael T. Siekman, a biotech IP expert who has been following this case since the late 1990s with Wolf, Greenfield & Sacks, P.C., an intellectual property law firm in Boston, can offer expert independent commentary on this landmark case.

Wolf Greenfield in Boston ( is one of the most experienced law firms specializing in intellectual property law, including patents, trademarks, copyrights, trade secrets, licensing and related litigation.

Contact Information